Idexx Laboratories IDXX
NASDAQ IDXX
$518.00 +4.86 (+0.95%)
At close: Oct 9, 2026 · 4:00 PM EDT

Idexx Laboratories (IDXX) Cash from Operations (2009 - 2026)

Updated

Idexx Laboratories (IDXX) recorded Cash from Operations of $347.16 million in Q2 2026, up 86.9% from $185.74 million a year earlier and up 30.4% from the prior quarter.

Analysis

Idexx Laboratories (IDXX) Cash from Operations (2009 - 2026) Analysis & Trends

On a TTM basis, Idexx Laboratories' Cash from Operations came in at $1.37 billion as of Jun 30, 2026, up 51.4% year-over-year; for FY2025, it was $1.18 billion, up 27.2% from FY2024.

  • Annual Cash from Operations has increased for three straight years, with a five-year compound annual growth rate of 12.8% (FY2020 to FY2025).
  • Across earlier years, Cash from Operations came in at $929 million in FY2024 (+2.5%), $906.51 million in FY2023 (+66.9%), $542.98 million in FY2022 (-28.1%) and $755.55 million in FY2021 (+16.6%).
  • Quarterly Cash from Operations has ranged from $65.85 million in Q2 2022 to $402.34 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Cash from Operations has increased for four consecutive quarters, with growth averaging 24.7% over the last eight quarters.
  • Peak year-over-year performance for Cash from Operations in the last five years was growth of 204.2% in Q2 2023, against a decline of 71.9% in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $266.25 million (Q1 2026), $355.76 million (Q4 2025) and $402.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,109.58 Bn 1,078.16 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 630.16 Bn 548.69 Bn 17.26 Bn 8.62 Bn
3 AbbVie 488.57 Bn 461.73 Bn 12.70 Bn 3.44 Bn
4 Merck 359.15 Bn 313.58 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 274.32 Bn 238.71 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 246.73 Bn 220.50 Bn 12.86 Bn 2.87 Bn
7 Amgen 224.28 Bn 179.68 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 187.60 Bn 161.71 Bn 6.22 Bn 3.57 Bn
9 Pfizer 161.13 Bn 108.08 Bn 10.94 Bn 835.00 Mn
10 Idexx Laboratories 40.86 Bn 40.07 Bn 779.09 Mn 347.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 347.16 Mn
Mar 31, 2026 266.25 Mn
Dec 31, 2025 355.76 Mn
Sep 30, 2025 402.34 Mn
Jun 30, 2025 185.74 Mn
Mar 31, 2025 237.96 Mn
Dec 31, 2024 262.03 Mn
Sep 30, 2024 220.08 Mn
Jun 30, 2024 248.31 Mn
Mar 31, 2024 198.59 Mn
Dec 31, 2023 249.85 Mn
Sep 30, 2023 272.43 Mn
Jun 30, 2023 200.31 Mn
Mar 31, 2023 183.91 Mn
Dec 31, 2022 173.43 Mn
Sep 30, 2022 189.00 Mn
Jun 30, 2022 65.85 Mn
Mar 31, 2022 114.71 Mn
Dec 31, 2021 209.96 Mn
Sep 30, 2021 187.21 Mn
API Access

Idexx Laboratories Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IDXX&period=max&api_key=YOUR_API_KEY